Access Bio (XKRX:950130) Total Stockholders Equity : ₩605,520 Mil (As of Mar. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Access Bio Total Stockholders Equity?

Access Bio's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ₩605,520 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Access Bio's Book Value per Share for the quarter that ended in Mar. 2024 was ₩17,908.50. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Access Bio's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.12.

Access Bio Total Stockholders Equity Historical Data

The historical data trend for Access Bio's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Access Bio Total Stockholders Equity Chart

Access Bio Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

24,567.69

83,721.18

286,589.74

618,111.84

584,155.18

Access Bio Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															642,562.47	611,143.15	614,375.01	584,155.18	605,520.49

Access Bio (XKRX:950130) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Access Bio's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(605520.487	-	0)	/	33.8119
	=	17,908.50

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Access Bio's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(13734.383	+	60460.295)	/	605520.487
	=	0.12

Access Bio Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Access Bio's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Access Bio (XKRX:950130) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Access Bio Inc (XKRX:950130) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

65 Clyde Road, Suite A, Somerset, NJ, USA, 08873

Website

http://www.accessbio.net

Access Bio Inc is a United States based bio company engaged in the research, development, and manufacturing of in vitro rapid diagnostic tests, biosensor, and molecular diagnostic products. The products are for the prevention and early diagnosis of infectious diseases. The company's core in vitro-diagnostic technology includes immunochemical, biochemical and molecular products. The company offers products for Rapid Diagnostic Tests including CareStart G6PD RDT, CareStart Malaria, CareStart Dengue Combo, and CareStart Scrub Typhus IgM; Biosensors product includes CareStart G6PD Biosensor, and Molecular Diagnostics products include CareStart HPV and CareStart CAH.

Access Bio (XKRX:950130) Headlines

No Headlines